The latest closing stock price for Cadrenal Therapeutics as of September 18, 2024 is 11.98.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $1,908 today, roughly 2 times their original investment - a 70.52% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 11.98 on September 18, 2024.
The Cadrenal Therapeutics 52-week high stock price is 13.00, which is 8.5% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 97% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 1.25.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $1,908 today, roughly 2 times their original investment - a 70.52% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 11.98 on September 18, 2024.
The Cadrenal Therapeutics 52-week high stock price is 13.00, which is 8.5% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 97% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 1.25.